LYVE1 and Alzheimer disease: Confocal images showed significantly enhanced LYVE-1 area coverage in AD mice after OT administration, accompanied by a concomitant increase in OVA-647 area coverage (Figure 4D-F), suggesting promoted drainage function benefiting from improved lymphatic structure.